Early Study Finds Huntingtin-lowering Compounds That Show Therapeutic Potential
Researchers have developed a new class of compounds that tackles the root cause of Huntington’s disease, opening up new avenues for the development of novel therapies for the disease. The compounds can lower the levels of mutant huntingtin — the faulty protein in Huntington’s disease — by sending it…